Orion Corporation: Managers’ transactions – Ari Lehtoranta

Group 1 - Orion Corporation has received a notification regarding transactions made by its board member Ari Lehtoranta, specifically concerning share-based incentives [1] - The transaction occurred on April 30, 2025, involving 508 shares at a unit price of 0 EUR, indicating a receipt of a share-based incentive [1] - Orion Corporation's net sales for 2024 amounted to EUR 1,542 million, and the company employs approximately 3,700 professionals globally [2] Group 2 - Orion Corporation operates as a Nordic pharmaceutical company with a focus on developing, manufacturing, and marketing both human and veterinary pharmaceuticals [2] - The company has a diverse portfolio that includes proprietary and generic medicines, as well as consumer health products, with core therapy areas in oncology and pain [2] - Orion's shares are listed on Nasdaq Helsinki, indicating its presence in the public market [2]